In NSCLC, KEAP1 deficiency is commonly observed in LUAD, while activating alterations of NFE2L2 are more prevalent in squamous cell lung carcinoma (~20%), with both alterations being mutually exclusive (108). This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.